Meeder Asset Management’s Co-Diagnostics CODX Stock Holding History

Meeder Asset Management’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-39	Closed	-$16K	–	1937
2020 Q3	$16K	Buy	+39	New	+$20K	﹤0.01%	1227

Other funds holding CODX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Meeder Asset Management's CODX Position: Q4 2020 in Review

Meeder Asset Management sold out of Co-Diagnostics (CODX) in Q4 2020, closing a stake of 39 shares — an estimated $16K sold.

Meeder Asset Management first reported a position in CODX in Q3 2020 and held it in 1 quarter. The position peaked at $16K in Q3 2020. 83 funds tracked by Wall St. Rank hold CODX as of Q4 2020.

Meeder Asset Management reported no remaining Co-Diagnostics position as of Q4 2020 after selling out during the quarter.
Meeder Asset Management sold 39 Co-Diagnostics shares in Q4 2020, an estimated $16K.
Meeder Asset Management first reported a position in Co-Diagnostics in Q3 2020 and held it in 1 quarter.
Meeder Asset Management's Co-Diagnostics position peaked at $16K in Q3 2020.
83 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.